References
- Bobillier P., Seguin S., Petitjean F. The raphe nuclei of the cat brainstem: a topographical atlas of their efferent projections as revealed by autoradiography. Brain Research 1976; 113: 449–486
- Brown R., Kocsis J., Caroff S., Amsterdam J., Winokur A., Stokes P., Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. American Journal of Psychiatry 1985; 142: 811–816
- Cameron O. G. Frequency of panic disorder in summer. American Journal of Psychiatry 1989; 146: 829–839
- Charney D. S., Heninger G. R., Breier A. Noradrenergic function in panic anxiety; effects of yohimbine in healthy subjects and patients with agorophobia and panic disorder. Archives of General Psychiatry 1984; 41: 751–763
- Coryell W., Endicott J., Andreasen N. C., Keller M. B., Clayton P. J., Hirschfeld R. M. A., Scheftner W. A., Winokur G. Depression and panic attacks: The significance of overlap as reflected in follow-up and family study data. American Journal of Psychiatry 1988; 145: 293–300
- Garvey M. J., Wesner R., Godes M. Comparison of seasonal and nonseasonal affective disorder. American Journal of Psychiatry 1988; 145: 100–102
- Gorman J. M., Liebowitz M. R., Fyer A. J., Stein J. A neuroanatomical hypothesis for panic disorder. American Journal of Psychiatry 1989; 146: 148–161
- Hoehn-Saric R., Merchant A. F., Keyser M. L. Effects of clonidine on anxiety disorders. Archives of General Psychiatry 1981; 38: 1278–1282
- Judd F., Norman T., Burrows G. The dexamethasone suppression test in panic disorder. Pharmacopsychiatry 1987; 20: 99–101
- Kaitin K. I., Bliwise D. L., Gleason C. Sleep disturbance produced by electrical stimulation of the locus ceruleus in a human subject. Biological Psychiatry 1986; 21: 710–716
- Kanofsky J. D., Sandyk R., Kaplan S., Yaryura-Tobias J. A. Seasonal panic disorder responsive to light therapy. Lancet 1991; 337: 1103–1104
- Kelly J. P. Cranial nerve nuclei, the reticular formation, and biogenic amines containing neurons. Principles of neural science, E. R. Kandel, J. H. Schwartz. Elsevier, New York 1985; 558–559
- Kendler K. S., Heath A. C., Martin N. G. Symptoms of anxiety and symptoms of depression: same genes, different syndromes. Archives of General Psychiatry 1987; 44: 451–457
- Klein D. F. Anxiety reconceptualized. Anxiety: new research and changing concepts, D. F. Klein, J. G. Rabkin. Raven Press, New York 1981
- Leckman J. F., Weissman M. M., Merikangas K. R. Panic disoder and major depression: increased risk of depression, alcoholism, panic, and phobic disorders in families of depressed probands with panic disorder. Archives of General Psychiatry 1983; 40: 1055–1060
- Lewy A. J., Sack R., Singer C. Immediate and delayed effects of bright light on human melatonin production: shifting dawn and dusk shifts the dim light melatonin onset (DLMO). Annals of the New York Academy of Sciences 1985; 453: 253–259
- Lewy A., Sack R., Miller S. Antidepressant and circadian phase-shifting effects of light. Science 1987; 235: 352–354
- Lewy A. J., Siever L. J., Uhde T. W., Markey S. P. Clonidine reduces plasma melatonin levels. Journal of Pharmacology and Pharmacy 1986; 38: 555–556
- McIntyre I., Marriott P., Jeffreys D. Reduced plasma melatonin in panic disorder. Biological Psychiatry 1986; 21: 1438–1439
- McIntyre I., Norman T., Marriott P. The pineal hormone melatonin in panic disorder. Journal of Affective Disorders 1987; 12: 203–206
- McIntyre I., Burrows G., Norman T. Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans. Biological Psychiatry 1988; 24: 105–108
- McIntyre I. M., Judd F. K., Burrows G. D., Armstrong S. M., Norman T. R. Plasma concentrations of melatonin in panic disorder. American Journal of Psychiatry 1990; 147: 462–464
- Mendlewicz J., Linkowski P., Brachey L. Abnormal 24-hour pattern of melatonin secretion in depression. Lancet 1979; 2: 1362
- Palazidou E., Papadopoulos A., Sitsen A., Stahl S., Checkley S. An alpha2 adrenoreceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man. Psychopharmacology 1989; 97: 115–117
- Pelayo F., Dubocovich M. L., Langer S. R. Regulation of noradrenaline release in the rat pineal through a negative feedback mechanism mediated by presynaptic alpha adrenoreceptors. European Journal of Pharmacology 1977; 45: 317–318
- Redmond D. E. Alterations in the function of the nucleus locus ceruleus: a possible model for the study of anxiety. Animal models in psychiatry and neurology, I. Hanin, E. Usdin. Pergamon Press, New York 1977
- Rosenthal N. E., Sack D. A., Gillin J. C. Seasonal affective disorder. Archives of General Psychiatry 1984; 41: 72–80
- Sanghera M. K., McMillen B. A., German D. C. Buspirone, a nonbenzodiazepine anxiolytic, increases locus ceruleus noradrenergic neuronal activity. European Journal of Pharmacology 1983; 86: 107–110
- Stein L., Wise C. D., Berger B. D. Antianxiety action of benzodiazepines decrease in activity of serotonin neurons in the punishment system. The benzodiazepines, S. Garattini, E. Mussini, L. O. Randall. Raven Press, New York 1973
- Torgersen S. Comorbidity of major depression and anxiety disorders in twin pairs. American Journal of Psychiatry 1990; 147: 1199–1202
- Wehr T. A., Rosenthal N. E. Seasonality and affective illness. American Journal of Psychiatry 1989; 146: 829–839
- Wetterberg L., Beck-Friis J., Aperia B. Melatonin/cortisol ratio in depression. Lancet 1979; 2: 1361